Chen John Z S, Jacobson Laurie G, Bakus Aboneal D, Garden Jerome M, Yaghmai Dina, Bernstein Leonard J, Geronemus Roy G
Division of Dermatology, University of Louisville, Louisville, Kentucky, USA.
Dermatol Surg. 2005 Mar;31(3):281-6. doi: 10.1111/j.1524-4725.2005.31074.
Topical anesthetics are important tools for many dermatologic procedures. The S-Caine Peel is composed of a 1:1 (w:w) eutectic mixture composed of lidocaine base 7%, USP, and tetracaine base 7%, USP. It is applied as a cream, dries on exposure to air, and forms a flexible membrane, which can be easily peeled off.
To evaluate the effectiveness of the S-Caine Peel in providing clinically useful local dermal anesthesia for laser-assisted tattoo removal and to monitor the nature and frequency of adverse events associated with the safety of the S-Caine Peel.
Thirty adult patients undergoing laser-assisted tattoo removal were enrolled in this multicentered, randomized, double-blind, placebo-controlled study. Each subject received both the S-Caine Peel and placebo simultaneously for 60 minutes. The primary efficacy parameter was a 100 mm visual analog scale (VAS) for patient self-assessment of pain. Secondary efficacy parameters included both the investigator's and an independent observer's evaluation of subject pain (4-point categorical scale: no pain through severe pain) and the patient's and the investigator's overall impression of the local anesthetic.
Mean VAS scores were 42 mm for the S-Caine Peel and 66 mm for placebo treatment sites (p=.001). Patients received adequate pain relief in 50% of S-Caine Peel sites versus 7% of placebo sites (p=.002). The percentage of those who would like to use the S-Caine Peel again were 43% for the S-Caine Peel compared with 7% for placebo (p=.005). Investigators' evaluations revealed that 70% of patients had less pain at S-Caine Peel treatment sites compared with 10% with less pain at placebo sites (p<.001), and 70% of the S-Caine Peel-treated sites achieved adequate anesthesia versus 10% of placebo sites (p<.001). The independent witness assessed less pain in 67% of S-Caine Peel-treated sites versus 10% of the placebo sites (p=.002). One occurrence of moderate to severe erythema was noted at both an S-Caine Peel and a placebo treatment site on removal of the S-Caine Peel after 60 minutes, which self-resolved quickly. There was no statistical difference between the two groups. Other side effects were limited to local mild, transient erythema at the application sites.
Administration of the S-Caine Peel for 60 minutes prior to laser-assisted tattoo removal was effective in significantly reducing pain levels associated with the procedure.
局部麻醉剂是许多皮肤科手术的重要工具。S-Caine Peel由1:1(重量比)的共晶混合物组成,包含7%(美国药典标准)的利多卡因碱和7%(美国药典标准)的丁卡因碱。它以乳膏形式涂抹,暴露于空气中会干燥,形成一层可轻松揭下的柔性膜。
评估S-Caine Peel在激光辅助纹身去除术中提供临床上有用的局部皮肤麻醉的有效性,并监测与S-Caine Peel安全性相关的不良事件的性质和频率。
30名接受激光辅助纹身去除术的成年患者参与了这项多中心、随机、双盲、安慰剂对照研究。每位受试者同时接受S-Caine Peel和安慰剂治疗60分钟。主要疗效参数是用于患者自我评估疼痛的100毫米视觉模拟量表(VAS)。次要疗效参数包括研究者和独立观察者对受试者疼痛的评估(4级分类量表:无痛至剧痛)以及患者和研究者对局部麻醉剂的总体印象。
S-Caine Peel治疗部位的平均VAS评分为42毫米,安慰剂治疗部位为66毫米(p = 0.001)。50%的S-Caine Peel治疗部位患者获得了充分的疼痛缓解,而安慰剂部位为7%(p = 0.002)。愿意再次使用S-Caine Peel的患者比例,S-Caine Peel组为43%,安慰剂组为7%(p = 0.005)。研究者的评估显示,70%的患者在S-Caine Peel治疗部位疼痛较轻,而安慰剂部位为10%(p < 0.001),70%的S-Caine Peel治疗部位实现了充分麻醉,而安慰剂部位为10%(p < 0.001)。独立观察者评估,67%的S-Caine Peel治疗部位疼痛较轻,而安慰剂部位为10%(p = 0.002)。在60分钟后揭下S-Caine Peel时,S-Caine Peel治疗部位和一个安慰剂治疗部位均出现了1例中度至重度红斑,均很快自行消退。两组之间无统计学差异。其他副作用仅限于涂抹部位局部轻度、短暂的红斑。
在激光辅助纹身去除术前60分钟使用S-Caine Peel可有效显著降低与该手术相关的疼痛程度。